Partnering and collaboration for pharma, biotechs, healthcare and investors
Adjuvants - a strategic component in modern vaccine
Adjuvants should be evaluated early in the vaccine development for optimum vaccine performance
Choosing the right adjuvants early in the research
Dr Karin Lovgren Bengtsson
CSO at Isconova since 2000
University degree in biochemistry, doctoral degree in virology, senior lecturer at the Swedish University of Agricultural Sciences and holder of seven patents
Has worked...
Director, Business Development at Isconova since 2010.
Masters Degree in Pharmaceutical Sciences and MBA from Henley Business School Extensive experience in sales, marketing and strategy from the...